These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


475 related items for PubMed ID: 18764843

  • 1. Folliculotropic mycosis fungoides (stage IIA) progressing to Sézary syndrome: a case report.
    Agar N, Whittaker SJ.
    Br J Dermatol; 2008 Nov; 159(5):1197-9. PubMed ID: 18764843
    [Abstract] [Full Text] [Related]

  • 2. Mycosis fungoides/Sézary syndrome: report of an unusual case.
    Mehta A, Dhungel BM, Khan MF.
    J Cutan Pathol; 2006 Sep; 33 Suppl 2():12-5. PubMed ID: 16972946
    [Abstract] [Full Text] [Related]

  • 3. Long-term outcome of 525 patients with mycosis fungoides and Sezary syndrome: clinical prognostic factors and risk for disease progression.
    Kim YH, Liu HL, Mraz-Gernhard S, Varghese A, Hoppe RT.
    Arch Dermatol; 2003 Jul; 139(7):857-66. PubMed ID: 12873880
    [Abstract] [Full Text] [Related]

  • 4. Molecular staging of lymph nodes from 60 patients with mycosis fungoides and Sézary syndrome: correlation with histopathology and outcome suggests prognostic relevance in mycosis fungoides.
    Fraser-Andrews EA, Mitchell T, Ferreira S, Seed PT, Russell-Jones R, Calonje E, Whittaker SJ.
    Br J Dermatol; 2006 Oct; 155(4):756-62. PubMed ID: 16965425
    [Abstract] [Full Text] [Related]

  • 5. Folliculotropic mycosis fungoides with follicular mucinosis--case report.
    Rados J, Dobrić I, Pasić A, Loncarić D, Manola I.
    Acta Dermatovenerol Croat; 2006 Oct; 14(2):94-9. PubMed ID: 16859615
    [Abstract] [Full Text] [Related]

  • 6. Survival outcomes and prognostic factors in mycosis fungoides/Sézary syndrome: validation of the revised International Society for Cutaneous Lymphomas/European Organisation for Research and Treatment of Cancer staging proposal.
    Agar NS, Wedgeworth E, Crichton S, Mitchell TJ, Cox M, Ferreira S, Robson A, Calonje E, Stefanato CM, Wain EM, Wilkins B, Fields PA, Dean A, Webb K, Scarisbrick J, Morris S, Whittaker SJ.
    J Clin Oncol; 2010 Nov 01; 28(31):4730-9. PubMed ID: 20855822
    [Abstract] [Full Text] [Related]

  • 7. T-cell receptor gamma gene rearrangement by multiplex polymerase chain reaction/heteroduplex analysis in patients with cutaneous T-cell lymphoma (mycosis fungoides/Sézary syndrome) and benign inflammatory disease: correlation with clinical, histological and immunophenotypical findings.
    Ponti R, Quaglino P, Novelli M, Fierro MT, Comessatti A, Peroni A, Bonello L, Bernengo MG.
    Br J Dermatol; 2005 Sep 01; 153(3):565-73. PubMed ID: 16120144
    [Abstract] [Full Text] [Related]

  • 8. [Clinicomorphological characteristics of Sezary's disease and mycosis fungoides].
    Vinogradova IuE, Giliazitdinova EA, Zamulaeva IA, Zybunova EE, Kaplanskaia IB, Kravchenko SK, Kremenetskaia AM, Lutsenko IN, Samoĭlova RS, Selivanova EN, Sidorova IuV, Shklovskiĭ-Kord NE.
    Ter Arkh; 2005 Sep 01; 77(10):61-5. PubMed ID: 16320688
    [Abstract] [Full Text] [Related]

  • 9. Abnormal expression of interleukin-23 in mycosis fungoides/Sézary syndrome lesions.
    Doherty SD, Ni X, Doherty CB, Jones D, Zhao X, Owen LB, Duvic M.
    Arch Dermatol Res; 2006 Dec 01; 298(7):353-6. PubMed ID: 17021762
    [Abstract] [Full Text] [Related]

  • 10. Mycosis fungoides and Sezary syndrome against a human immunodeficiency virus-positive background: case report.
    Gahongayire F.
    Int J Dermatol; 2007 Oct 01; 46 Suppl 1():32-5. PubMed ID: 17919204
    [Abstract] [Full Text] [Related]

  • 11. Folliculotropic mycosis fungoides: an aggressive variant of cutaneous T-cell lymphoma.
    Gerami P, Rosen S, Kuzel T, Boone SL, Guitart J.
    Arch Dermatol; 2008 Jun 01; 144(6):738-46. PubMed ID: 18559762
    [Abstract] [Full Text] [Related]

  • 12. The spectrum of hair loss in patients with mycosis fungoides and Sézary syndrome.
    Bi MY, Curry JL, Christiano AM, Hordinsky MK, Norris DA, Price VH, Duvic M.
    J Am Acad Dermatol; 2011 Jan 01; 64(1):53-63. PubMed ID: 21036417
    [Abstract] [Full Text] [Related]

  • 13. Folliculotropic mycosis fungoides.
    Hunzeker CM, Fangman W, Latkowski JA.
    Dermatol Online J; 2007 Jan 27; 13(1):5. PubMed ID: 17511938
    [Abstract] [Full Text] [Related]

  • 14. Mycosis fungoides and the Sézary syndrome.
    Kim YH, Hoppe RT.
    Semin Oncol; 1999 Jun 27; 26(3):276-89. PubMed ID: 10375085
    [Abstract] [Full Text] [Related]

  • 15. Prognosis of 100 Japanese patients with mycosis fungoides and Sézary syndrome.
    Suzuki SY, Ito K, Ito M, Kawai K.
    J Dermatol Sci; 2010 Jan 27; 57(1):37-43. PubMed ID: 19931424
    [Abstract] [Full Text] [Related]

  • 16. Juvenile folliculotropic and ichthyosiform mycosis fungoides.
    Ryan C, Whittaker S, D'Arcy C, O'Regan GM, Rogers S.
    Clin Exp Dermatol; 2009 Jul 27; 34(5):e160-2. PubMed ID: 19094122
    [Abstract] [Full Text] [Related]

  • 17. Management of mycosis fungoides. Part 1. Diagnosis, staging, and prognosis.
    Smith BD, Wilson LD.
    Oncology (Williston Park); 2003 Sep 27; 17(9):1281-8. PubMed ID: 14569854
    [Abstract] [Full Text] [Related]

  • 18. [Clinicopathological differential diagnosis of mycosis fungoides/Sézary syndrome from the cutaneous type of adult T-cell leukemia/lymphoma].
    Johno M, Ono T.
    Nihon Rinsho; 2000 Mar 27; 58(3):660-4. PubMed ID: 10741142
    [Abstract] [Full Text] [Related]

  • 19. Prognostic factors in erythrodermic mycosis fungoides and the Sézary syndrome.
    Kim YH, Bishop K, Varghese A, Hoppe RT.
    Arch Dermatol; 1995 Sep 27; 131(9):1003-8. PubMed ID: 7661601
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 24.